Known targets — ChEMBL curated mechanism
ADRA2AADRA2BADRA2CADRB2AGTR1AVPR1AAVPR1BAVPR2BDKRB2CALCRCHRNA3CHRNB4ESR1ESR2GHSRGNRHRGSC1HSPA8MALT1MC1RMC4RNOS1NOS2NOS3OPRK1OXTRRAMP1RAMP2RAMP3SCN5ASSTR1SSTR2SSTR3SSTR4SSTR5dacAdacBdacCfolPftsImrcAmrcBmrdArplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Acetic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.51 |
| ▸ | TSHR | P16473 | 1/20 | 0.51 |
| ▸ | BLM | P54132 | 1/20 | 0.49 |
| ▸ | RECQL | P46063 | 1/20 | 0.49 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.49 |
| ▸ | MEN1 | O00255 | 1/20 | 0.49 |
| ▸ | LRAT | O95237 | 1/20 | 0.49 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.49 |
| ▸ | LMNA | P02545 | 1/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.47 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.47 |
| ▸ | FGF1 | P05230 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Acetic Acid SCHEMBL28127820 | 1.00 | HSD17B10 (0.51) | HSD17B10TSHRBLMRECQLTDP1 | |
| Acetic Acid SCHEMBL7937547 | 1.00 | HSD17B10 (0.51) | HSD17B10TSHRBLMRECQLTDP1 | |
| Acetic Acid SCHEMBL7935270 | 1.00 | HSD17B10 (0.51) | HSD17B10TSHRBLMRECQLTDP1 | |
| SCHEMBL8886136 | 0.92 | TSHR (0.57) | HSD17B10TSHRBLMRECQLTDP1 | |
| SCHEMBL19090413 | 0.92 | TSHR (0.57) | HSD17B10TSHRBLMRECQLTDP1 | |
| SCHEMBL24372177 | 0.92 | TSHR (0.57) | HSD17B10TSHRBLMRECQLTDP1 | |
| SCHEMBL19074569 | 0.92 | TSHR (0.57) | HSD17B10TSHRBLMRECQLTDP1 | |
| SCHEMBL8886131 | 0.92 | TSHR (0.57) | HSD17B10TSHRBLMRECQLTDP1 | |
| SCHEMBL21916330 | 0.92 | TSHR (0.57) | HSD17B10TSHRBLMRECQLTDP1 | |
| SCHEMBL23259481 | 0.92 | TSHR (0.57) | HSD17B10TSHRBLMRECQLTDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 57 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3436820-A2 | DETECTING MICROBIAL INFECTION IN WOUNDS | Qualizyme Diagnostics GmbH&Co KG (AT) | 2019-02-06 | — | — | EP | claimed |
| WO-2017168249-A2 | DETECTING MICROBIAL INFECTION IN WOUNDS | QUALIZYME DIAGNOSTICS GMBH & CO KG (AT) | 2017-10-05 | — | — | WO | claimed |
| US-20260071050-A1 | BIODEGRADABLE POLYMER COMPOSITIONS | INTERFACIAL CONSULTANTS LLC (US) | 2026-03-12 | — | — | US | disclosed |
| US-12466894-B2 | Anti-MUC16 antibodies and uses thereof | MEMORIAL SLOAN KETTERING CANCER CENTER (US) | 2025-11-11 | — | — | US | disclosed |
| US-12371581-B2 | High performance water soluble polymer compositions | INTERFACIAL CONSULTANTS LLC | 2025-07-29 | — | — | US | disclosed |
| US-20250041443-A1 | COMPOSITIONS FOR INTRODUCING RNA INTO CELLS | ETHRIS GMBH (DE) | 2025-02-06 | — | — | US | disclosed |
| EP-4427678-A2 | DETECTING MICROBIAL INFECTIONS IN WOUNDS | ConvaTec Technologies Inc. (US) | 2024-09-11 | — | — | EP | disclosed |
| EP-4426778-A1 | BIODEGRADABLE POLYMER COMPOSITIONS | Interfacial Consultants LLC (US) | 2024-09-11 | — | — | EP | disclosed |
| US-12064484-B2 | Compositions for introducing RNA into cells | ETHRIS GMBH (DE) | 2024-08-20 | — | — | US | disclosed |
| EP-3936095-B1 | DETECTING MICROBIAL INFECTIONS IN WOUNDS | CONVATEC TECHNOLOGIES INC (US) | 2024-06-19 | — | — | EP | disclosed |
| US-11723808-B2 | Detecting microbial infections in wounds | CONVATEC TECHNOLOGIES INC. (US) | 2023-08-15 | — | — | US | disclosed |
| EP-3110954-A1 | COMPOSITIONS FOR GASTROINTESTINAL ADMINISTRATION OF RNA | Ethris GmbH (DE) | 2017-01-04 | — | — | EP | disclosed |
| WO-2016149368-A1 | ANTI-MUC16 ANTIBODIES AND USES THEREOF | MEMORIAL SLOAN KETTERING CANCER CENTER (US) | 2016-09-22 | — | — | WO | disclosed |
| US-20160215033-A1 | Granulocyte Macrophage Colony-Stimulating Factor Compositions | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH (US) | 2016-07-28 | — | — | US | disclosed |
| CN-105579584-A | Compositions for introducing RNA into cells | ETHRIS GMBH | 2016-05-11 | — | — | CN | disclosed |
| EP-3013964-A1 | COMPOSITIONS FOR INTRODUCING RNA INTO CELLS | ethris GmbH (DE) | 2016-05-04 | — | — | EP | disclosed |
| WO-2015128030-A1 | COMPOSITIONS FOR GASTROINTESTINAL ADMINISTRATION OF RNA | ETHRIS GMBH (DE) | 2015-09-03 | — | — | WO | disclosed |
| WO-2015034920-A2 | GRANULOCYTE MACROPHAGE COLONY-STIMULATING FACTOR COMPOSITIONS | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH (US) | 2015-03-12 | — | — | WO | disclosed |
| WO-2014207231-A1 | COMPOSITIONS FOR INTRODUCING RNA INTO CELLS | ETHRIS GMBH (DE) | 2014-12-31 | — | — | WO | disclosed |
| WO-2013166053-A2 | HOMOGENOUS AND FULLY GLYCOSYLATED HUMAN ERYTHROPOIETIN | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH (US) | 2013-11-07 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12064484-B2 | Compositions for introducing RNA into cells | NSUN3, ABCB4, RNMT | HSD17B10 1188/4885TSHR 4129/4885BLM 1377/4885 |
| US-20250041443-A1 | COMPOSITIONS FOR INTRODUCING RNA INTO CELLS | NSUN3, ABCB4, RNMT | HSD17B10 1188/4885TSHR 4129/4885BLM 1377/4885 |
| US-20160215033-A1 | Granulocyte Macrophage Colony-Stimulating Factor Compositions | CSF3R, CSF1R, GMFG | HSD17B10 3709/4885TSHR 2656/4885BLM 4230/4885 |
| US-20260071050-A1 | BIODEGRADABLE POLYMER COMPOSITIONS | PGD, MPDU1, MGAM | HSD17B10 2819/4885TSHR 4042/4885BLM 2344/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.